{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:18:00Z","timestamp":1781763480142,"version":"3.54.5"},"reference-count":43,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>Superficial fungal infections of the hair, skin and nails are a major cause of morbidity in the world. Choosing the right treatment is not always simple because of the possibility of drug interactions and side effects. The first part of the article discusses the main treatments for superficial mycoses - keratophytoses, dermatophytosis, candidiasis, with a practical approach to the most commonly-used topical and systemic drugs , referring also to their dosage and duration of use. Promising new, antifungal therapeutic alternatives are also highlighted, as well as available options on the Brazilian and world markets.<\/jats:p>","DOI":"10.1590\/abd1806-4841.20132018","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T14:05:24Z","timestamp":1392386724000},"page":"937-944","source":"Crossref","is-referenced-by-count":29,"title":["Treatment of superficial mycoses: review - part II"],"prefix":"10.1590","volume":"88","author":[{"given":"Maria Fernanda Reis Gavazzoni","family":"Dias","sequence":"first","affiliation":[{"name":"Santa Casa da Miseric\u00f3rdia do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Bernardes-Filho","sequence":"additional","affiliation":[{"name":"Santa Casa da Miseric\u00f3rdia do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vict\u00f3ria Pinto","family":"Quaresma-Santos","sequence":"additional","affiliation":[{"name":"Santa Casa da Miseric\u00f3rdia do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Gutstein da Fonseca","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Casz","family":"Schechtman","sequence":"additional","affiliation":[{"name":"London University; Santa Casa da Miseric\u00f3rdia do Rio de Janeiro, Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Rubem","family":"Azulay","sequence":"additional","affiliation":[{"name":"Santa Casa da Miseric\u00f3rdia do Rio de Janeiro, Brazil; Rio de Janeiro Pontifical Catholic University; Souza Marques Foundation; Rio de Janeiro Federal University, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Dermatology in general medicine","first-page":"1807","volume-title":"Superficial fungal infection: dermatophytosis, tinea nigra, piedra","author":"Verma S","year":"2008","edition":"7th ed"},{"key":"ref2","series-title":"Rook's Textbook of Dermatology","first-page":"36.5","volume-title":"Superficial mycoses","author":"Hay RJ","year":"2010","edition":"8th ed"},{"key":"ref3","series-title":"Dermatology","first-page":"1135","volume-title":"Fungal diseases","author":"Sobera JO","year":"2008","edition":"2nd ed"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00003495-200969030-00009","article-title":"Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynecology","volume":"69","author":"Croxtall JD","year":"2009","journal-title":"Drugs"},{"key":"ref5","series-title":"Tratado de Micologia M\u00e9dica (Medical Mycology Treaty).Lacaz","first-page":"252","author":"Lacaz CS","year":"2002","edition":"9. ed"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11046-008-9109-0","article-title":"Update in antifungal therapy of dermatophytosis","volume":"166","author":"Gupta AK","year":"2008","journal-title":"Mycopathologia"},{"key":"ref7","series-title":"Microbiology medical","first-page":"404","volume-title":"Superficial, cutaneous and subcutaneous mycosis","author":"Murray PR","year":"1994","edition":"2nd ed"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1067\/mjd.2000.110380","article-title":"Overview: the treatment of dermatophytosis","volume":"43","author":"Rand S","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0190-9622(99)70395-6","article-title":"Oral therapy of common superficial fungal infection of the skin","volume":"40","author":"Lesher JL","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"ref10","series-title":"Goodman & Gilman: as bases farmacol\u00f3gicas da terap\u00eautica (Goodman and Gilman's: the pharmacological basis of therapeutics)","volume-title":"Agentes Antif\u00fangicos (Antifungal Agents)","author":"Hardman JG","year":"2003","edition":"10. ed"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.det.2007.01.002","article-title":"Advances in topical and systemic antifungals","volume":"25","author":"Zhang AY","year":"2007","journal-title":"Dermatol Clin"},{"key":"ref12","series-title":"Dermatologia (Dermatology)","first-page":"419","volume-title":"Micoses superficiais (Superficial Mycoses)","author":"Azulay RD","year":"2011","edition":"5"},{"key":"ref13","series-title":"Drug eruptions & reactions manual: D.E.R.M.","author":"Litt JZ","year":"2012","edition":"18th ed"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.1999.00007.x","article-title":"Onychomycosis: current treatment and future challenges","volume":"141","author":"Roberts DT","year":"1999","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000335093","article-title":"Efficacious treatment of non-dermatophyte mould onychomycosis with topical amphotericin B","volume":"223","author":"Lurati M","year":"2011","journal-title":"Dermatology"},{"key":"ref16","series-title":"Fundamentos de Dermatologia (Fundaments of Dermatology)","first-page":"879","volume-title":"Micoses superficiais (Superficial Mycoses)","author":"Ramos-e-Silva M","year":"2010"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1529-8019.2009.01276.x","article-title":"Superficial cutaneous fungal infections in tropical countries","volume":"22","author":"Charles AJ","year":"2009","journal-title":"Dermatol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QCO.0b013e328359a56e","article-title":"Making sense of posaconazole therapeutic drug monitoring: a practical approach","volume":"25","author":"Ananda-Rajah MR","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"ref19","first-page":"165","article-title":"Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole","volume":"11","author":"Pasqualotto AC","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2133.2003.05418.x","article-title":"In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity","volume":"149","author":"Gupta AK","year":"2003","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00228-012-1305-7","article-title":"Interaction between amorolfine and acenocoumarol","volume":"68","author":"Morales-Molina JA","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/j.1326-5377.2007.tb01313.x","article-title":"Antifungal agents","volume":"187","author":"Chen SC","year":"2007","journal-title":"Med J Aust"},{"key":"ref23","first-page":"258","article-title":"Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens","volume":"15","author":"Cetinkaya Z","year":"2005","journal-title":"Eur J Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1468-3083.2005.01284.x","article-title":"Treatment options - development of consensus guideline","volume":"19","author":"Lecha M","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0190-9622(99)70055-1","article-title":"Drug interactions with itraconazole, fluconazole, and terbinafine and their management","volume":"41","author":"Gupta AK","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/095466302317584395","article-title":"A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff\/seborrhoeic dermatitis","volume":"13","author":"Squire RA","year":"2002","journal-title":"J Dermatolog Treat"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200203020-00001","article-title":"Six novel antimycotics","volume":"3","author":"Rubin AI","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"ref28","first-page":"390","article-title":"New aspects in the diagnosis and therapy of dermatomycoses","volume":"63","author":"Brasch J","year":"2012","journal-title":"Hautarzt"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/eri.10.163","article-title":"Newer antifungal agents","volume":"9","author":"T\u00fcrel O","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1439-0507.2006.01228.x","article-title":"In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans","volume":"49","author":"Sigle HC","year":"2006","journal-title":"Mycoses"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1439-0507.1997.tb00227.x","article-title":"The hydroxypyridones: a class of antimycotics of its own","volume":"40","author":"Korting HC","year":"1997","journal-title":"Mycoses"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000211515","article-title":"In vitro susceptibility testing of Malassezia furfur against rilopirox","volume":"10","author":"Nenoff P","year":"1997","journal-title":"Skin Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/13693780903373811","article-title":"Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model","volume":"48","author":"Ghannoum MA","year":"2010","journal-title":"Med Mycol"},{"key":"ref34","first-page":"311","article-title":"Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes","volume":"53","author":"Ghannoum MA","year":"2010","journal-title":"Mycoses"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10156-004-0327-1","article-title":"In vitro antifungal activity of luliconazole (NND502), a novel imidazole antifungal agent","volume":"10","author":"Uchida K","year":"2004","journal-title":"J Infect Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0105-1873.2004.00271j.x","article-title":"Contact dermatitis due to lanoconazole, cetyl alcohol and diethyl sebacate in lanoconazole cream","volume":"50","author":"Soga F","year":"2004","journal-title":"Contact Dermatitis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/13693780802541518","article-title":"In vitro antifungal activities of luliconazole, a new topical imidazole","volume":"47","author":"Koga H","year":"2009","journal-title":"Med Mycol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0924-8579(02)00362-X","article-title":"In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species","volume":"21","author":"Uchida K","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/2229-5178.73249","article-title":"Studies on comparison of the efficacy of terbinafine 1% cream and butenafine 1% cream for the treatment of Tinea cruris","volume":"1","author":"Das S","year":"2010","journal-title":"Indian Dermatol Online J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1517\/17425255.4.7.999","article-title":"Butenafine and superficial mycoses: current status","volume":"4","author":"Singal A","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0378-6323.93651","article-title":"Eberconazole--pharmacological and clinical review","volume":"78","author":"Moodahadu-Bangera LS","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-4632.2006.02841.x","article-title":"Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double blind, comparative trial with miconazole 2% cream","volume":"45","author":"Repiso Montero T","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11046-012-9540-0","article-title":"Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature","volume":"174","author":"Keshtkar-Jahromi M","year":"2012","journal-title":"Mycopathologia"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v88n6\/0365-0596-abd-88-06-0937.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:42Z","timestamp":1747666842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962013000600937&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0365-05962013000600937"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20132018","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}